Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients

Background: Active Vitamin D analogues are used clinically for prevention and treatment of secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. Nutritional vitamin D supplementation is used for additional local parathyroid (PTH) suppression, with lower incidence of hypercalcemia and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jing-Quan, Hou, Yi-Chou, Zheng, Cai-Mei, Lu, Chien-Lin, Liu, Wen-Chih, Wu, Chia-Chao, Huang, Ming-Te, Lin, Yuh-Feng, Lu, Kuo-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133095/
https://www.ncbi.nlm.nih.gov/pubmed/27827962
http://dx.doi.org/10.3390/nu8110708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133095/
https://www.ncbi.nlm.nih.gov/pubmed/27827962
http://dx.doi.org/10.3390/nu8110708

Ejemplares similares